Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOPE-2 Study
NCT00106886Phase 4Unknown
- Sponsor
- Hamilton Health Sciences
- Start
- Dec 1999
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of folic acid, pyridoxine, vitamin b12 in cardiovascular disease (CVD), diabetes mellitus (DM), sponsored by Hamilton Health Sciences. Status: unknown.
02
Drugs
folic acidpyridoxinevitamin b12
03
Conditions
cardiovascular disease (CVD)diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT00106886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00106886.